Clinical and experimental research of immunomodulatory effect of amisulpride

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 12, 2012, Pages 13-17

  Vetlugina, T P ^a   Lobacheva, O A ^a   AIperina, E L ^b   Zhukova, E N ^b   Semke, A V ^a   Nikitina, V B ^a   Cheido, M A ^b   Idova, G V ^b  

^a MENTAL HEALTH RESEARCH INSTITUTE   (Russian Federation)

^b SCIENTIFIC RESEARCH INSTITUTE OF PHYSIOLOGY AND BASIC MEDICINE   (Russian Federation)

Author keywords

Amisulpride; C57BL 6J mice; Cellular immunity; Humoral immunity; IgM immune response; Schizophrenia

Indexed keywords

EID: 84875780067     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: 10.15690/vramn.v67i12.475     Document Type: Article

References (6)

1. Muller N., Schwarz M. Immunology in schizophrenic disorders. Nervenarzt. 2007; 78 (3): 253-256, 258-260, 262-263.
2. Devoino L., Idova G., Alperina E., Cheido M. Brain neuromediator systems in the immune response control: pharmacological analysis of pre- and postsynaptic mechanisms. Brain Res. 1994; 633: 267-274. (Pubitemid 24021270)
3. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2 (high) receptors. CNS Neurosci Ther. 2011; 17(2): 118-132.
4. Wfctanabe Y., Someya T, Nawa H. Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin. Neurosci. 2010; 64 (3): 217-230.
5. Devoino L., Alperina E., Galkina O., Ilyutchenok R. Involvement of brain dopaminergic structures in neuroimmunomodulation. Intern. J. Neurosci. 1997; 91 (3-4): 213-228. (Pubitemid 27490965)
6. Idova G.V., Alperna E.L., Cheido M.A. Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis. Int. Immunopharmacol. 2012; 12 (4): 618-625.